Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:12:10 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 2.280 AUD | +0.44% |
|
-2.56% | -32.54% |
| 08-27 | Clarity Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-26 | Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up | MT |
| Market Cap | 851M 613M 528M 496M 453M 848M 57.89B 5.87B 2.28B 29.7B 2.3B 2.25B 95.69B | P/E 2027 * |
-7.83x | P/E 2028 * | -9.8x |
|---|---|---|---|---|---|
| Enterprise Value | 786M 567M 488M 459M 419M 784M 53.52B 5.42B 2.1B 27.46B 2.13B 2.08B 88.47B | EV / Sales 2027 * |
843x | EV / Sales 2028 * | 12.4x |
| Free-Float |
79.07% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CU6 | Delayed | |
OTC Markets
| CLRPF | Delayed | |
|
Tradegate
| 1F4 | Real-time | |
|
Deutsche Boerse AG
| 1F4 | Delayed |
| 1 day | +0.44% | ||
| 1 week | -2.56% | ||
| 1 month | -3.39% | ||
| 3 months | -1.30% | ||
| 6 months | -33.14% | ||
| Current year | -32.54% |
| 1 week | 2.2 |  | 2.48 |
| 1 month | 2.2 | | 2.96 |
| Current year | 1.8 | | 4.26 |
| 1 year | 1.8 | | 5.87 |
| 3 years | 0.98 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 2024-10-10 |
Matthew Harris
CEO | Chief Executive Officer | - | 2009-12-31 |
David Green
DFI | Director of Finance/CFO | - | 2022-04-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 72 | 2016-03-28 |
Thomas Ramdahl
BRD | Director/Board Member | 70 | 2019-02-28 |
Alan Taylor
CHM | Chairman | - | 2013-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/22/26 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 11/28/25 | Free | Chief Operating Officer | 199,909 | 0.0537% | ||
| 11/28/25 | Free | Chief Operating Officer | 287,530 | 0.0773% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.44% | -2.56% | -26.45% | +119.23% | 609M | |
| -1.79% | -3.82% | +38.74% | +91.90% | 69.02B | |
| -2.06% | -1.52% | +46.40% | +86.87% | 66.32B | |
| -0.31% | +6.54% | -11.39% | +378.92% | 27.66B | |
| +0.86% | +1.65% | +0.25% | -14.95% | 25.84B | |
| -3.00% | -2.61% | +34.45% | +11.39% | 26.54B | |
| -1.46% | -0.09% | +24.64% | -18.36% | 20.4B | |
| -2.96% | -16.03% | +213.13% | +375.00% | 17.63B | |
| -1.49% | -6.69% | -4.69% | +539.74% | 15.15B | |
| -0.20% | +8.37% | +57.87% | +164.98% | 14.65B | |
| Average | -1.20% | -0.89% | +37.29% | +173.47% | 28.38B | |
| Weighted average by Cap. | -1.53% | -0.46% | +40.09% | +138.84% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 933K 673K 579K 545K 498K 931K 63.52M 6.44M 2.5M 32.59M 2.53M 2.47M 105M | 61.76M 44.52M 38.31M 36.04M 32.92M 61.59M 4.2B 426M 165M 2.16B 167M 164M 6.95B |
| Net income | -120M -86.52M -74.45M -70.04M -63.98M -120M -8.17B -828M -321M -4.19B -325M -318M -13.5B | -88.68M -63.93M -55.01M -51.76M -47.28M -88.44M -6.04B -612M -237M -3.1B -240M -235M -9.98B |
| Net Debt | -64.16M -46.25M -39.8M -37.44M -34.2M -63.99M -4.37B -442M -172M -2.24B -174M -170M -7.22B | -87.22M -62.87M -54.1M -50.9M -46.5M -86.98M -5.94B -601M -233M -3.05B -236M -231M -9.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | A$2.280 | +0.44% | 1,445,326 |
| 26-09-03 | A$2.270 | 0.00% | 1,294,035 |
| 26-09-02 | A$2.270 | -2.58% | 1,903,792 |
| 26-09-01 | A$2.330 | +2.19% | 1,679,992 |
| 26-08-31 | A$2.280 | -9.16% | 2,935,877 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
